Study of B/F/TAF in Participants Switching From CAB + RPV to B/F/TAF for HIV-1 Infection (EMPOWER)
Clinical trial NCT06104306 · COMPLETED
Trial details
- NCT number
- NCT06104306
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-13
- Primary completion
- 2025-01-29
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.